Table 1.
Participant characteristics of the analytic sample at the first (EBT1) and last (EBT4) Healthy Women Study (HWS) visits (n=148).
| EBT1 Follow-Up Visit | EBT4 Follow-Up Visit | |
|---|---|---|
| Agea, years | 61.9 ± 1.7 | 73.2 ± 1.7 |
| Body mass indexa, kg/m2 | 27.2 ± 5.2 | 27.3 ± 5.1 |
| Waist circumferencea, cm | 83.1 ± 12.9 | 89.7 ± 13.2 |
| Cardiovascular Risk Factors | ||
| Systolic blood pressurea, mmHg | 121.7 ± 18.3 | 123.8 ± 20.4 |
| Diastolic blood pressurea, mmHg | 71.3 ± 8.9 | 65.4 ± 10.9 |
| Total cholesterola, mg/dL | 215.2 ± 34.8 | 218.4 ± 45.9 |
| Low density lipoproteina, mg/dL | 129.0 ± 34.2 | 126.7 ± 40.6 |
| High density lipoproteina, mg/dL | 61.6 ± 17.1 | 67.7 ± 14.4 |
| Triglyceridesa, mg/dL | 126.0 ± 74.6 | 119.3 ± 50.4 |
| Glucosea, mg/dL | 91.0 ± 14.1 | 103.4± 14.2 |
| Insulina, mU/dL | --- | 13.1 ± 5.1 |
| Current cigarette smokerb | 8.2 (3.7, 12.6) | 0.0 (0.0, 0.0) |
| No detectable coronary artery calcificationb | 56.1 (48.1, 64.1) | 25.0 (18.0, 32.0) |
| Medication Use | ||
| Current hormone therapy useb | 55.8 (47.4, 63.8) | 4.7 (1.3, 8.2) |
| Hormone therapy use duration, yearsc | 4.5 (2.0, 7.0) | 22.4 (3.2, 24.8) |
| Current lipid lowering medication useb, | 6.1 (2.2, 9.9) | 46.0 (37.9, 54.0) |
| Current hypertension medication useb | 10.1 (5.2, 15.0) | 48.7 (40.6, 56.7) |
| Current diabetes medication useb | --- | 6.1 (2.2, 9.9) |
| Physical activity (PA)* | ||
| Self-reported leisure time PAc, kcal·wk−1 | 1848.7 ± 309.8 | --- |
| Self-reported leisure time PAc, MET·hr·wk−1 | --- | 18.0 ± 4.3 |
| Accelerometer- derived estimates | ||
| Wear timea, min/d | --- | 1042.2 ± 114.5 |
| Total accelerometer countsc, cts/d | --- | 172873.0 ± 7834.0 |
| Sedentarya, min/d | --- | 745.3 ± 108.7 |
| Light intensity PAc, min/d | --- | 227.7 ± 2.9 |
| Moderate- to Vigorous- intensity PAc, min/d | --- | 61.8 ± 4.8 |
| Moderate- to Vigorous- Intensity PA boutsc, min/d | --- | 14.3 ± 6.6 |
*
Self-reported leisure time physical activity was assessed using the Paffenbarger Physical Activity Questionnaire at the EBT1 visit and the Modifiable Activity Questionnaire at EBT4.
Presented as: amean ± standard deviation; b percent (95% confidence interval); cmedian (interquartile range)
c
A square-root transformation was applied; data are back-transformed and presented as mean ± standard deviation